147 related articles for article (PubMed ID: 34976998)
1. Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells
Liu X; Qiao K; Zhu K; Li X; Zhao C; Li J; Feng D; Fang Y; Wang P; Qian C; Qiao W
Front Cell Dev Biol; 2021; 9():675082. PubMed ID: 34976998
[TBL] [Abstract][Full Text] [Related]
2. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
3. LncRNA
Yang Y; Gong P; Yao D; Xue D; He X
Cancer Manag Res; 2021; 13():2287-2294. PubMed ID: 33732021
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer.
Liu Y; Lin W; Dong Y; Li X; Lin Z; Jia J; Zou W; Pan Y
Cancer Med; 2020 Sep; 9(18):6752-6765. PubMed ID: 32725768
[TBL] [Abstract][Full Text] [Related]
5. HNF1A-Induced lncRNA HCG18 Facilitates Gastric Cancer Progression by Upregulating DNAJB12 via miR-152-3p.
Ma P; Li L; Liu F; Zhao Q
Onco Targets Ther; 2020; 13():7641-7652. PubMed ID: 32801777
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis.
Zou Y; Sun Z; Sun S
J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HLA Complex Group 18 (HCG18) Facilitated Cell Proliferation, Invasion, and Migration of Prostate Cancer Through Modulating miR-370-3p/DDX3X Axis.
Pan X; Chen G; Hu W
Reprod Sci; 2021 Dec; 28(12):3406-3416. PubMed ID: 34708395
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HOTAIR promotes the proliferation and invasion/metastasis of breast cancer cells by targeting the miR-130a-3p/Suv39H1 axis.
He W; Li D; Zhang X
Biochem Biophys Rep; 2022 Jul; 30():101279. PubMed ID: 35619625
[TBL] [Abstract][Full Text] [Related]
9. CircPVT1 Promoted the Progression of Breast Cancer by Regulating MiR-29a-3p-Mediated AGR2-HIF-1α Pathway.
Wang J; Huang K; Shi L; Zhang Q; Zhang S
Cancer Manag Res; 2020; 12():11477-11490. PubMed ID: 33223849
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/β-catenin.
Li S; Wu T; Zhang D; Sun X; Zhang X
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):703-712. PubMed ID: 31854468
[TBL] [Abstract][Full Text] [Related]
11. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway.
Li L; Ma TT; Ma YH; Jiang YF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10387-10399. PubMed ID: 31841193
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer.
Xin L; Wu Y; Liu C; Zeng F; Wang JL; Wu DZ; Wu JP; Yue ZQ; Gan JH; Lu H; Yuan YW; Zhou LQ
Mol Immunol; 2021 Dec; 140():196-205. PubMed ID: 34735868
[TBL] [Abstract][Full Text] [Related]
14. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X
Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer.
Liu H; Bian QZ; Zhang W; Cui HB
Oncol Lett; 2022 Jan; 23(1):38. PubMed ID: 34966454
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
18. Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses.
Li S; Wang X; Wang T; Zhang H; Lu X; Liu L; Li L; Bo C; Kong X; Xu S; Ning S; Wang J; Wang L
J Transl Med; 2021 Nov; 19(1):468. PubMed ID: 34794447
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
20. Blocking lncRNA HCG18 re-sensitizes Taxol resistant lung cancer cells to Taxol through modulating the miR-34a-5p/HDAC1 axis.
Zhang F; Wang J; Li H; Luo X; Xu Q; Liu L; Xu Y; Yang K; Liu Z; Gong R
J Chemother; 2024 May; ():1-12. PubMed ID: 38706347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]